The price of Bayer Korea's anticancer drug Nexavar 200mg (Sorafenib tosylate) will be reduced by 30% next month. It is a government control. After that, at the end of the year, the benefits that have been given the premium will end and fall further.

The price of Dong-A ST's postmenopausal osteoporosis treatment Teribone inj 56.5μg (teriparatide) will rise by nearly 31% by the beginning of 2021. According to industry sources on the 21st, the MOHW is pushing ahead with the revision of the 'pharmaceutical benefit list and upper limit price table'. The actual application date differs for each item.

◆ End of addition = addition of Bayer Korea's Nexavar 200mg ends next month and the drug pric